A Study of Olanzapine in Participants With Bipolar Disorder.

Boryung

Status: Enrolling

Conditions: Bipolar Disorder

Treatments: Drug: Olanzapine

Study type: Observational

Funder types: Industry

Identifiers

NCT07263191

BR-OLZ-OS-401

Details and patient eligibility

About

This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have signed the informed consent after receiving information about the purpose and method of this study.
• Patients diagnosed with bipolar disorder and scheduled to receive olanzapine.
• Patients who understand the contents of the survey and can answer the questions directly.

Exclusion criteria

• Female patients who are pregnant, have childbearing potential, or are breastfeeding.
• Has received an investigational product within 12 weeks from the study enrollment or has plans to participate in another clinical trial during the participation of this study.
• Other subjects who are considered inappropriate to participate in this study by the judgment of the investigator.